Ergostik CPET System
Cardio-Pulmonary Exercise Testing
- Breath-by-breath gas exchange analysis
- Flowsensor with new variable orifice design offering extreme low dead space
- Full integration into diagnostic software platform Blue Cherry
- Automatic detection of anaerobic threshold (AT) and respiratory compensation point (RCP)
- Smart Report Technology providing flexible, user defined Reports
- Wasserman Interpretation chart
- Automatic BTPS adjustment
- Full Spirometry (FVC, SVC, MVV, Pre/Post and bronchial challenge test)
- Integrated Pulsoximetry (optional)
- Training Planner (optional)
- Integrated 12 Lead Rest- and Stress-ECG
- Integrated Polar Heart Rate receiver (optional)
- Indirect Calorimetry (optional)
- Resting Energy Expenditure REE (optional)
Description
The Ergostik CPET System is a powerful CPET (Cardio-Pulmonary Exercise Testing) device for use with patients or athletes. It enables diagnosis of cardiac diseases, pulmonary diseases and cardiovascular diseases as well as being a powerful tool for performance diagnostics and preoperative assessments. It provides an insight into the complex interaction between pulmonary, cardiac, cardio-circulatory system and metabolism and offers a high level of diagnostic significance, because of this Ergostik offers one of the most powerful tools for diagnosis of patients with unclear dyspnea.
At the pinnacle of cardiopulmonary exercise diagnostics, the Ergostik CPET system is a powerful machine used in a wide array of fields from simple fitness tests and sports medicine through respiratory differential diagnosis for dyspnea to the latest peri-operative diagnostics. At its core lies the superlight (<20g) Ergoflow flow sensor, offering patients the utmost comfort during the performance of the exercise test. The powerful BLUE CHERRY® diagnostic platform provides the backbone for all testing, analysis and reporting, measuring flow rate O2 and CO2 throughout the entire test. From these simple measured values, Ergostik under BLUE CHERRY® enables the user to easily determine important ventilatory and respiratory parameters such as the maximum oxygen uptake (VO2max). Assisting the user to determine aerobic-anaerobic threshold values AT and RCP and helping to simplify the interpretation of data. Utilising the collected data BLUE CHERRY® uses additional software modules to create and adapt individual training plans for patients, especially endurance and strength training plans for athletes. The Ergostik is completed with the measurement of spirometry data such as flow volume measurement and MVV.
The Ergostik™ metabolic unit represents the next generation of cardiopulmonary diagnostic exercise equipment.
The powerful Blue Cherry® software platform coupled with the highest quality hardware provides market leading performance allowing users to run accurate complete exercise tests quickly and easily. The new Ergoflow flow sensor draws on an incredible variable orifice design which prevents the increase in flow resistance at increase flow rates found with most flow sensors. The water vapour insensitive Ergoflow is considerably lighter and has a lower deadspace than competitors offerings, ensuring precise and reliable testing.
Online interpretation according to the accepted guidelines and predicted sets by Professor Wasserman allows the clincian to evaluate the test data via his published flow charts for accurate interpretation. Blue Cherry offers multiple user definable graphical and tabular screen playouts whilst automatic Anaerobic Threshold (AT) determination with review means that you can be confident with you results.
Ergostik™ includes Spirometry and dynamic exercise flow volume loops as standard, ensuring that users have all of the necessary tools at hand to provide comprehensive cardiopulmonary assessment.
The comprehensive database options provide complete networking flexibility. Multiple devices can be networked together, sharing the same database across the hospital or university network, even from different sites or from a group of practices. Review stations allow remote access of patient data for review and interpretation.